AI-generated summary
The authors reviewed randomised controlled trials of second-generation antidepressants for preventing seasonal affective disorder in adults with a history of winter-type SAD. Four publications from three trials, including 1100 people, met criteria, and the authors report that bupropion XL was associated with fewer recurrent depressive episodes but more headaches, insomnia and nausea. No studies of other antidepressants or comparator interventions were found.
- Participants
- 1,100
- Studies included
- 3
- Who or what was studied
- Adults with a history of winter-type seasonal affective disorder who were symptom-free at study entry
- Limits stated in the abstract
- The authors note that all three trials had methodological limitations due to high attrition rates, and the evidence on other antidepressants is absent.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Heterogeneity, Confidence interval, Publication bias, Risk of bias, Attrition, Insomnia, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.